Results

Total Results: 1,187 records

Showing results for "week".

221. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - would also need access to a highly trained, multidisciplinary care team 24 hours a day, 7 days a week … of the DURATION trial series, which included the six randomized, comparator-controlled, 24- to 30-week … Duration-1 three- year and Duration-3 84-week data presented at ADA 2011. [internet]. … sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week … Intarcia presents positive phase 2 48-week results from ITCA 650 study at the American Diabetes Association

222. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - institutionalized patients sooner because they had prescrip- tions for shorter durations, often no longer than 1 week … Anonymous PharmaNet data on dispensed drugs in the early and delayed groups were available each week.

223. labor-dystocia-protocol-amended-160728 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-dystocia_research-protocol.pdf
     July 28, 2016 - labor-dystocia-protocol-amended-160728 Source: www.effectivehealthcare.ahrq.gov Published online: July 28, 2016 Evidence-based Practice Center Systematic Review Protocol Project Title: Labor Dystocia Initial publication date if applicable: January 27, 2016 Amendment Date(s) if applicable: July 12, 2016 (…

224. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - During the 12-week followup period after discontinuing treatment, people in both liraglutide groups … Liraglutide was generally well tolerated, and the 56-week completion rate for liraglutide 3 mg, liraglutide … The third trial (SCALE™ Obesity and Prediabetes) was a 56-week, double-blind RCT evaluating liraglutide … Sixty-nine percent of the 3 mg liraglutide group showed no signs of prediabetes at 56 week followup … The 56-week completion rate for liraglutide 3 mg and placebo groups was 72% and 64%, respectively.

225. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - plus topiramate 92 mg.5 Clinical trials: In 2013, Davidson and colleagues announced results of a 56-week … In 2011, Allison and colleagues announced results from a 56-week clinical trial (EQUIP) evaluating … 2.1% in the placebo group (p<0.0001); in the ITT-LOCF analysis, LS mean percent weight loss at week … During the 12- week follow-up period after treatment discontinuation, people in both liraglutide … The 56-week completion rate was 72% and 64% for liraglutide 3 mg and placebo, respectively.

226. American Medical Association (AMA) App Challenge and AMA Idealab (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/eaagleston.pdf
     May 29, 2025 - American Medical Association (AMA) App Challenge and AMA Idealab INNOVATIONS CONFERENCE -- AMA SPEAKERS: ROBERT HICKS, BUSINESS PROCESS DEVELOPMENT DIRECTOR, AMA BRIAN EAGGLESTON, PHYSICIAN OUTREACH AND RETENTION, AMA HICKS: I'm Bob Hicks. I'm business process development director …

227. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - biloba coadministered with aspirin and/or pentoxyphilline during a 4-week underpowered study in 33 … Dietary Supplement Control(s) Outcome Measures Conclusions Omega-3 Fatty acids Miller 20137 12-week … Bays 201210 12-week multi-center randomized controlled double blinded trial of Icosapent ethyl( … /exclusion criteria) CVD Drug Dietary Supplement Control(s) Outcome Measures Conclusions 24-week … mg qd(+aspirin (<325mg) EPC+DHA, escalating doses (1, 2, 4, and 8 gm, qd) in consecutive 6-week

228. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fetal-surgery_disposition-comments.pdf
     July 05, 2011 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week … that the progression of TTTS isnot only not linear, but is as likely to improve as toworsen from week … to week (Luks FI, Carr SR, PlevyakM, Craigo SD, Athanassiou A, Ralston SJ, Tracy TF Jr.Limited prognostic

229. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
     July 01, 2023 - Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer Rapid Response July 2023 Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer Main Points Background Disorders of the teeth, gums, …

230. FRN 22: Future Research Needs for Strategies To Reduce Cesarean Birth in Low-Risk Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth_research.pdf
     January 01, 2020 - Does cesarean use correlate with specific days of the week or time of day? 14. … Prioritizing of these research needs via a web-based ranking system (two week access to online site). … Prioritizing the refined list of needs via web-based ranking system (two week access to online site). … Does cesarean use correlate with specific days of the week or time of day? 14. … 6 Does use of cesareans correlate with specific days of the week or time of day?

231. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
     June 01, 2022 - 2 hours; pain free, sustained pain free, and pain relief at 1 day; and sustained pain free at 1 week … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … ; 1 week to <2 weeks; 2 weeks to 4 weeks? … attention control, and no treatment after followup at the following intervals: <1 day; 1 day to <1 week … ; 1 week to <2 weeks; 2 weeks to 4 weeks?

232. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - dates. 3 The Text2Quit program was launched in the United States in June 2011. 2 In results of a 4-week … demonstrated superiority of the implant over placebo in opioid-negative urine screens over the 24-week

233. Disposition of Comments: Comparative Effectiveness Review No. 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-episodic-migraine-comments.pdf
     December 29, 2020 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week

234. Treating Infantile Hemangiomas in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
     June 01, 2016 - Treating Infantile Hemangiomas in Children Treating Infantile Hemangiomas in Children A Review of the Research for Parents and Caregivers e Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current. Archived: This report is greater than 3…

235. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week … I believe many alcohol experts would consider 1 drink per drinking day (7 drinks a week) a clinically … alcohol pharmacotherapy trial that I reviewed, if there is an effect of a medication, you see if by week … patients (n=53, 8% of the total study population) who abstained completely from drinking during the week … included 54 placebo subjects of which over 50% of the subjects (34) dropped out before completing the 12 week

236. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
     June 16, 2010 - The recommended adult starting dose is 150 Units/kg SC 3 times per week or 40,000 Units SC weekly. … The recommended initial dose is 30,000 IU per week given as one injection per week or in divided … doses 3 to 7 times per week. … patients were allocated by alternation, the use of case record numbers, dates of birth or day of week

237. Febrile-Infants-Diagnosis-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
     March 01, 2012 - Literature Search Studies were identified through electronic searches in MEDLINE (1950 to September Week … MEDLINE in Process (September 29, 2010), CINAHL (1982–2008, OVID Interface), Embase (1980 to 2010 Week … 37, OVID interface), PsycINFO (1806 to September Week 2 2010 OVID interface), EBM Reviews, Cochrane … A week-by-week analysis of the low-risk criteria for serious bacterial infection in febrile neonates … Failure of infant observation scales in detecting serious illness in febrile, 4- to 8-week-old infants

238. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
     April 01, 2010 - At VAGLAHS, following a week-long training and one-week pilot, three experienced nurse abstractors abstracted … for spinal cord compression then there should be follow-up of neurologic symptoms and signs within 1 week … pleural effusion undergoes thoracentesis, then there should be a repeat assessment of dyspnea within one week

239. Kidney-Disease-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
     October 01, 2012 - Increases were maintained through week 52 with significant decreases of 5.8+/- 1.8ml, 10.5+/-1.8ml, … (LSD) or regular sodium (RSD)diet 52 Patients with non-diabetic nephropathy Proteinuria 4, 6 week

240. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - dates. 3 The Text2Quit program was launched in the United States in June 2011. 2 In results of a 4-week … demonstrated superiority of the implant over placebo in opioid-negative urine screens over the 24-week